The protocol for expression of proteins makes use of expression vectors, competent cells, reagents, instrument, and services. The reagents are the estimated to hold the largest share due to the large volume used in the bio-experiments. The significant growth in the protein expression market is primarily due to the increasing funds from government and non-government organization for protein research, the soaring prevalence of chronic diseases, rising life science industry.
Request for Free Sample Copy of this Research Report at: https://www.vynzresearch.com/healthcare/protein-expression-market/request-sample
Among the various systems being used in the market, the prokaryotic expression system is the largest contributor with 39.7% share in the protein expression market in 2017, globally. This category includes escherichia coli systems, and other prokaryotic expression systems. The largest share of prokaryotic expression system is due to the cost-effectiveness, as it is less expensive over other available categories; and the wide usage of E.coli systems in industries. Other types of systems used in the market include yeast systems, mammalian cell, insect cell, cell-free systems, and algal-based systems.
Pharmaceutical and biotechnology companies are the largest end user in the protein expression market. The category’s largest contribution is due to the large production of recombinant proteins for therapeutics, and the growing advancement in technology with respect to protein research. Further, other end users to the protein expression market includes academic research institutes, contract research organizations (CROs), others industries such as food processing, brewery, leather, paper, chemical and cosmetic industries. The CROs are projected to witness high demand and register fastest CAGR of 13.7% during the forecast period.
Geographically, North America is the largest market for protein expression products and services, globally. The largest contribution of the region is due to the adaptation of technologically advanced products, and the increasing government and non-government funds for protein research.
The major player in the global protein expression industry includes New England Biolabs, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Takara Bio Inc., Lonza Group Ltd., Merck KGaA, Promega Corporation, Genscript Biotech Corporation, Agilent Technologies Inc., and Bio-Rad Laboratories, Inc.
Read Full Research Report Description at: https://www.vynzresearch.com/healthcare/protein-expression-market
The market players are launching new and technologically advanced products and services to maintain their competency and market share. For instance, in March 2018, Aragen Bioscience, Inc. announced the expansion of its RapTr cell line development services to be included in CHO-GS cell lines. The addition of suite protein expression and analytical services will provide flexibility in the development of cell lines and the generation of high-quality proteins.
Source: VynZ Research